Top Markets
Coin of the day
Nichi-Iko Pharmaceutical Co., Ltd. Nichi-Iko Pharmaceutical Co., Ltd.

Nichi-Iko Pharmaceutical Co., Ltd.

4541
Rank in Stocks #8954
Nichi-Iko Pharmaceutical Co., Ltd. actively manufactures, distributes, imports,... Nichi-Iko Pharmaceutical Co., Ltd. actively manufactures, distributes, imports, and sells a wide variety of pharmaceutical products. Operating through its Sagent Group and Nichi-Iko Group segments, the company primarily focuses on the development and production of generic drugs. Its extensive product line encompasses antidiabetic, antacid, and antireflux agents, as well as beta-blockers, hypnotics, sedatives, angiotensin II antagonists (including combinations with diuretics), dyslipidemic agents, and calcium antagonists. These offerings target conditions affecting the circulatory, digestive, respiratory, central, and peripheral nervous systems, among others. Beyond pharmaceuticals, the company is also involved in packaging design and exports its products internationally. Established in 1947 as Nihon Iyakuhin Kogyo Co., Ltd., the firm officially became Nichi-Iko Pharmaceutical Co., Ltd. in 2005 and is headquartered in Toyama, Japan.
Share Price
$0.22167204
Last synced: 2024-08-21
Market Cap
$1.13B
Change (1 day)
1.08%
Change (1 year)
0.00%
Country
JP
Trade Nichi-Iko Pharmaceutical Co., Ltd. (4541)

Category

EPS for Nichi-Iko Pharmaceutical Co., Ltd. (4541)
EPS as of 2026 TTM: 0
According to Nichi-Iko Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Nichi-Iko Pharmaceutical Co., Ltd. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors